Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Integr Biol (Camb). 2011 Sep;3(9):879-86. doi: 10.1039/c1ib00034a. Epub 2011 Jul 29.

    Intracellular mechanisms of aminoglycoside-induced cytotoxicity.

    Source

    Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA. karasawa@ohsu.edu

    Abstract

    Since introduction into clinical practice over 60 years ago, aminoglycoside antibiotics remain important drugs in the treatment of bacterial infections, cystic fibrosis and tuberculosis. However, the ototoxic and nephrotoxic properties of these drugs are still a major clinical problem. Recent advances in molecular biology and biochemistry have begun to uncover the intracellular actions of aminoglycosides that lead to cytotoxicity. In this review, we discuss intracellular binding targets of aminoglycosides, highlighting specific aminoglycoside-binding proteins (HSP73, calreticulin and CLIMP-63) and their potential for triggering caspases and Bcl-2 signalling cascades that are involved in aminoglycoside-induced cytotoxicity. We also discuss potential strategies to reduce aminoglycoside cytotoxicity, which are necessary for greater bactericidal efficacy during aminoglycoside pharmacotherapy.

    PMID:
    21799993
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3662252
    Free PMC Article

    Images from this publication.See all images (3)Free text

    Fig. 1
    Fig. 2
    Fig. 3

      Supplemental Content

      Icon for Royal Society of Chemistry Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk